Hormone replacement therapy, reproductive factors, and cataract: The Blue Mountains Eye Study

American Journal of Epidemiology

Volumn 145, Issue 3, 1997, Pages 242-249

  Cumming, Robert G ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cataract; estrogen replacement therapy; menarche; menopause; risk factors

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; AUSTRALIA; CATARACT; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

EID: 0031016833     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009097     Document Type: Article

References (18)

1. Grady D, Rubin SM, Petitti DB, et al. Hormone replacement therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
2. Klein BEK, Klein R, Ritter L. Is there evidence of an estrogen effect on age-related lens opacities? Arch Ophthalmol 1994;112:85-91.
3. Leske MC, Sperduto RD. The epidemiology of senile cataract: a review. Am J Epidemiol 1983;118:152-65.
4. Mitchell P, Smith W, Attebo K, et al. The prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
5. Klein BEK, Klein R, Linton KLP, et al. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 1990;97:1428-33.
6. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population. Ophthalmology 1992;99:546-52.
7. Cruikshank KJ, Klein BEK, Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health 1992;82:1658-62.
8. Klein BEK, Klein R, Linton KLP, et al. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med 1993;9:27-30.
9. Ritter LL, Klein BE, Klein R, et al. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch Opthalmol 1993;111:113-17.
10. Mares-Perlman JA, Brady WE, Klein BEK, et al. Diet and nuclear lens opacities. Am J Epidemiol 1995;141:322-34.
11. Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol 1989;129:191-204.
12. Toogood JH, Markov AE, Baskerville J, et al. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol 1993;91:571-9.
13. Cauley JA, Seeley DG, Ensrud K, et al. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
14. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
15. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Cantares R, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286-94.
16. Niki E, Nakano M. Estrogens as antioxidants. Methods Enzymol 1990;186:330-3.
17. Sperduto RD, Tian-Sheng H, Milton RC, et al. The Linxian Cataract Studies. Two nutrition intervention trials. Arch Ophthalmol 1993;111:1246-53.
18. Lumb G, Mitchell L, de la Iglesia FA. Regression of pathologic changes induced by the long-term administration of contraceptive steroids to rodents. Toxicol Pathol 1985;13:283-95.